← 產業報告目錄
Plasma Fractionation Market Size, Share & Trends Analysis Report By Product (Immune-Globulins, Coagulation Factor Concentrates, Albumin, Protease Inhibitors, Other Plasma Products), By Application, By End-User, By Region, And By Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-26頁數 179報告編號 INSIGHTACE-8ef66b0c10
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
In 2023, the Plasma Fractionation Market worldwide was assessed at USD 4.2 Bn. Analysts project it will progress to USD 8.9 Bn by 2031, at a CAGR of 10.1% spanning 2024 to 2031.
Plasma Fractionation covers key industry insights & findings from the report:
The demand for plasma-derived therapies has been mounting due to the rising prevalence of immune deficiencies, respiratory infections, including ot. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
Market momentum is underpinned by mounting call for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
From a regional perspective, mature markets in North America and Europe continue to hold marked shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and mounting investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Plasma Fractionation Market Snapshot
Chapter 4. Global Plasma Fractionation Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Application Estimates & Trend Analysis
5.1. By Application, & Market Share, 2019 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Application:
5.2.1. Neurology
5.2.2. Immunology
5.2.3. Hematology
5.2.4. Critical Care
5.2.5. Pulmonology
5.2.6. Hemato-Oncology
5.2.7. Rheumatology
5.2.8. Others
Chapter 6. Market Segmentation 2: By Product Estimates & Trend Analysis
6.1. By Product & Market Share, 2019 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Product:
6.2.1. Immune-Globulins
6.2.1.1. Intravenous Immune-Globulins
6.2.1.2. Subcutaneous Immune-Globulins
6.2.1.3. Other Immune-Globulins
6.2.2. Coagulation Factor Concentrates
6.2.2.1. Factor VIII
6.2.2.2. Factor IX
6.2.2.3. Von Willebrand Factor
6.2.2.4. Prothrombin Complex Concentrate
6.2.2.5. Fibrinogen Concentrates
6.2.2.6. Factor XIII
6.2.2.7. Others
6.2.3. Albumin
6.2.4. Protease Inhibitors
6.2.5. Other Plasma Products
Chapter 7. Market Segmentation 3: By Distribution Channel Estimates & Trend Analysis
7.1. By Distribution Channel & Market Share, 2019 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Distribution Channel:
7.2.1. Hospitals & Clinics
7.2.2. Clinical Research Laboratories
7.2.3. Academic Institutes
Chapter 8. Plasma Fractionation Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Plasma Fractionation Market revenue (US$ Million) estimates and forecasts By Application, 2019-2031
8.1.2. North America Plasma Fractionation Market revenue (US$ Million) estimates and forecasts By Product, 2019-2031
8.1.3. North America Plasma Fractionation Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2019-2031
8.1.4. North America Plasma Fractionation Market revenue (US$ Million) estimates and forecasts by country, 2019-2031
8.2. Europe
8.2.1. Europe Plasma Fractionation Market revenue (US$ Million) By Application, 2019-2031
8.2.2. Europe Plasma Fractionation Market revenue (US$ Million) By Product, 2019-2031
8.2.3. Europe Plasma Fractionation Market revenue (US$ Million) By Distribution Channel, 2019-2031
8.2.4. Europe Plasma Fractionation Market revenue (US$ Million) by country, 2019-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Plasma Fractionation Market revenue (US$ Million) By Application, 2019-2031
8.3.2. Asia Pacific Plasma Fractionation Market revenue (US$ Million) By Product, 2019-2031
8.3.3. Asia Pacific Plasma Fractionation Market revenue (US$ Million) By Distribution Channel, 2019-2031
8.3.4. Asia Pacific Plasma Fractionation Market revenue (US$ Million) by country, 2019-2031
8.4. Latin America
8.4.1. Latin America Plasma Fractionation Market revenue (US$ Million) By Application, (US$ Million) 2019-2031
8.4.2. Latin America Plasma Fractionation Market revenue (US$ Million) By Product, (US$ Million) 2019-2031
8.4.3. Latin America Plasma Fractionation Market revenue (US$ Million) By Distribution Channel, (US$ Million) 2019-2031
8.4.4. Latin America Plasma Fractionation Market revenue (US$ Million) by country, 2019-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Plasma Fractionation Market revenue (US$ Million) By Application, (US$ Million) 2019-2031
8.5.2. Middle East & Africa Plasma Fractionation Market revenue (US$ Million) By Product, (US$ Million) 2019-2031
8.5.3. Middle East & Africa Plasma Fractionation Market revenue (US$ Million) By Distribution Channel, (US$ Million) 2019-2031
8.5.4. Middle East & Africa Plasma Fractionation Market revenue (US$ Million) by country, 2019-2031
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們